Literature DB >> 6609722

Induction of a substrate for casein kinase II during lymphocyte mitogenesis.

R L Geahlen, M L Harrison.   

Abstract

Particulate fractions prepared from concanavalin A-activated murine T lymphocytes contain an endogenous protein kinase that phosphorylates an endogenous protein substrate of Mr 112 000. The phosphorylation of 112 kDa protein is greatly reduced or absent in unstimulated T cells. Phosphoamino acid analysis indicates that 112 kDa protein is labeled on a serine. Add-back experiments using purified protein kinases indicate that 112 kDa protein serves as a substrate for casein kinase II. Phosphorylation of 112 kDa protein by the endogenous kinase is inhibited by heparin, a known casein kinase II inhibitor. The site or sites modified by the endogenous kinase and exogenous casein kinase II appear identical by peptide-mapping experiments. A time-course of the appearance of phosphorylated 112 kDa protein following stimulation with concanavalin A, measured in the presence or absence of added casein kinase II, suggests that 112 kDa protein is induced in activated T cells. Subcellular localization studies suggest that 112 kDa protein is a nuclear protein. Silver-binding and purification studies suggest that 112 kDa protein is of the nucleolar organizing region.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6609722     DOI: 10.1016/0167-4889(84)90146-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Localization of the casein kinase II beta-subunit gene within the mouse H-2 complex class III region and comparison of expression with Bat genes.

Authors:  D Lanning; W P Lafuse
Journal:  Mamm Genome       Date:  1997-07       Impact factor: 2.957

2.  Mitosis-specific phosphorylation of nucleolin by p34cdc2 protein kinase.

Authors:  P Belenguer; M Caizergues-Ferrer; J C Labbé; M Dorée; F Amalric
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

3.  Acidic protein kinases of Polysphondylium violaceum: characterization and developmental regulation.

Authors:  H Flotow; J F Wheldrake
Journal:  Mol Cell Biochem       Date:  1988-11       Impact factor: 3.396

4.  Differential distribution of protein kinases along the crypt-to-lumen regions of rat colonic epithelium.

Authors:  B Schwartz; G M Fraser; J Levy; Y Sharoni; R Guberman; J Krawiec; S A Lamprecht
Journal:  Gut       Date:  1988-09       Impact factor: 23.059

5.  Co-ordinated changes in the cyclic AMP signalling system and the phosphorylation of two nuclear proteins of Mr 130,000 and 110,000 during proliferative stimulation of the rat parotid gland by isoprenaline. Possible identity of the two proteins with pp135 and nucleolin.

Authors:  J Hoffmann; G Schwoch
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

6.  Stimulation of enzymatic activity in filament preparations of casein kinase II by polylysine, melittin, and spermine.

Authors:  M D Mamrack
Journal:  Mol Cell Biochem       Date:  1989-02-21       Impact factor: 3.396

7.  The Gly/Arg-rich (GAR) domain of Xenopus nucleolin facilitates in vitro nucleic acid binding and in vivo nucleolar localization.

Authors:  M A Heine; M L Rankin; P J DiMario
Journal:  Mol Biol Cell       Date:  1993-11       Impact factor: 4.138

8.  Induced expression of nucleolin phosphorylation-deficient mutant confers dominant-negative effect on cell proliferation.

Authors:  Shu Xiao; Elif Caglar; Priscilla Maldonado; Dibash Das; Zaineb Nadeem; Angela Chi; Benjamin Trinité; Xin Li; Anjana Saxena
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

9.  Hyperphosphorylation of N-60, a protein structurally and immunologically related to nucleolin after tumour-promoter treatment.

Authors:  O G Issinger; T Martin; W W Richter; M Olson; H Fujiki
Journal:  EMBO J       Date:  1988-06       Impact factor: 11.598

10.  Evidence for the induction of casein kinase II in bovine lymphocytes transformed by the intracellular protozoan parasite Theileria parva.

Authors:  O K ole-MoiYoi; W C Brown; K P Iams; A Nayar; T Tsukamoto; M D Macklin
Journal:  EMBO J       Date:  1993-04       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.